Bright-light therapy during prostate cancer treatment: fatigue and mood study
About this title
Read the official source — NCT05869682Understand this study
Who could participate?
Listed age limits: from 60 years.
What will I do during this study?
Participants continue standard prostate-cancer treatment and are randomly assigned to start bright-white-light glasses immediately or after six months. The immediate group uses the glasses for 12 months; the delayed group uses them for the final six months. The study follows participants for 52 weeks and collects fatigue, mood and quality-of-life measures.
- Listed locations
- DuarteSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 210
- Sponsor
- City of Hope Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER, PROCEDURE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 60 Years
- Official registry ID
- NCT05869682
- Official title
Show the full official title
Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)
Recruitment & locations
Duarte
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is City of Hope Medical Center, a hospital or academic medical center.
Who can participate?
Listed age limits: from 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
